Incidence of peptic ulcer bleeding in the US pediatric population.

Clinical applicability of the incidence of pediatric peptic ulcer bleeding in the United States. J Pediatr Gastroenterol Nutr (2012) 0.75

The impact of balloon catheter dilation on frequency of sinus surgery in the United States. Med Devices (Auckl) (2014) 0.75

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology (2004) 4.42

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology (2005) 3.41

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology (2002) 3.21

Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology (2002) 2.66

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology (2002) 2.35

A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet (2003) 2.17

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol (2006) 2.14

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol (2007) 2.14

Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06

Higher order wavefront aberrations and topography in early and suspected keratoconus. J Refract Surg (2007) 1.81

Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol Genet Metab (2004) 1.81

Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol (2006) 1.79

Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol (2012) 1.74

Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation (2008) 1.68

Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med (2004) 1.65

Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr (2007) 1.56

Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet (2007) 1.48

Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes (2004) 1.44

Longitudinal study of the normal eyes in unilateral keratoconus patients. Ophthalmology (2004) 1.43

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy. Hepatology (2007) 1.42

Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med (2003) 1.38

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis (2007) 1.33

Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain (2005) 1.28

Genomewide linkage scan in a multigeneration Caucasian pedigree identifies a novel locus for keratoconus on chromosome 5q14.3-q21.1. Genet Med (2005) 1.27

A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease. Am J Gastroenterol (2008) 1.27

TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis (2007) 1.24

A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A (2007) 1.24

No VSX1 gene mutations associated with keratoconus. Invest Ophthalmol Vis Sci (2006) 1.23

Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes (2005) 1.23

NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology (2006) 1.20

Two-stage genome-wide linkage scan in keratoconus sib pair families. Invest Ophthalmol Vis Sci (2006) 1.20

Hierarchical assembly of ZnO nanostructures on SnO(2) backbone nanowires: low-temperature hydrothermal preparation and optical properties. ACS Nano (2009) 1.19

Three VSX1 gene mutations, L159M, R166W, and H244R, are not associated with keratoconus. Cornea (2008) 1.18

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. J Hepatol (2008) 1.17

Longitudinal study of keratoconus progression. Exp Eye Res (2007) 1.14

A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke (2005) 1.13

Keratoconus: classification scheme based on videokeratography and clinical signs. J Cataract Refract Surg (2009) 1.13

Flexible ultraviolet random lasers based on nanoparticles. Small (2005) 1.10

Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology (2006) 1.08

Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol Genet Metab (2004) 1.01

Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension (2005) 0.99

Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J Clin Gastroenterol (2006) 0.98

Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor. Circulation (2007) 0.97

Gene responsible for mitochondrial myopathy and sideroblastic anemia (MSA) maps to chromosome 12q24.33. Am J Med Genet A (2004) 0.97

Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol (2010) 0.96

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology (2007) 0.95

Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol (2007) 0.95

Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study. Diabetes (2005) 0.93

Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol (2006) 0.92

Cell membrane is impaired, accompanied by enhanced type III secretion system expression in Yersinia pestis deficient in RovA regulator. PLoS One (2010) 0.91

The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. J Clin Endocrinol Metab (2005) 0.90

Genetic effects on obesity assessed by bivariate genome scan: the Mexican-American coronary artery disease study. Obesity (Silver Spring) (2006) 0.89

Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril (2005) 0.89

Outer membrane proteins ail and OmpF of Yersinia pestis are involved in the adsorption of T7-related bacteriophage Yep-phi. J Virol (2013) 0.88

Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr (2007) 0.88

Autoregulation of PhoP/PhoQ and positive regulation of the cyclic AMP receptor protein-cyclic AMP complex by PhoP in Yersinia pestis. J Bacteriol (2012) 0.87

Plasmid-encoding extended-spectrum β-lactamase CTX-M-55 in a clinical Shigella sonnei strain, China. Future Microbiol (2014) 0.87

Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. J Pediatr (2009) 0.87

Yersinia protein kinase A phosphorylates vasodilator-stimulated phosphoprotein to modify the host cytoskeleton. Cell Microbiol (2014) 0.86

Genome-wide linkage analysis using cross-sectional and longitudinal traits for body mass index in a subsample of the Framingham Heart Study. BMC Genet (2003) 0.86

Can a meta-analysis answer the question: is mucosectomy and handsewn or double-stapled anastomosis better in ileal pouch-anal anastomosis? Am Surg (2006) 0.86

IL-17A produced by neutrophils protects against pneumonic plague through orchestrating IFN-γ-activated macrophage programming. J Immunol (2013) 0.85

Gene expression profiling of Yersinia pestis with deletion of lcrG, a known negative regulator for Yop secretion of type III secretion system. Int J Med Microbiol (2008) 0.84

The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis (2005) 0.84

Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease. Inflamm Bowel Dis (2010) 0.82

Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study. Clin Ther (2006) 0.82

Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts. Genet Med (2004) 0.80

Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study. Clin Ther (2006) 0.80

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C. Antimicrob Agents Chemother (2008) 0.79

Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. J Pediatr (2013) 0.79

Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis. Scand J Gastroenterol (2010) 0.78

Transcriptional regulation of the waaAE-coaD operon by PhoP and RcsAB in Yersinia pestis biovar Microtus. Protein Cell (2014) 0.78

Single-dose pharmacokinetic properties of esomeprazole in children aged 1 - 11 years with endoscopically proven GERD: a randomized, open-label study. Int J Clin Pharmacol Ther (2014) 0.78

Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. J Pediatr Gastroenterol Nutr (2010) 0.77

Sensitization to omeprazole in the occupational setting. Contact Dermatitis (2014) 0.77

Current status of the Chinese National Twin Registry. Twin Res Hum Genet (2006) 0.77

CRP acts as a transcriptional repressor of the YPO1635-phoPQ-YPO1632 operon in Yersinia pestis. Curr Microbiol (2014) 0.77

A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model. Vaccine (2013) 0.77

Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age. Clin Ther (2012) 0.77

Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge. Clin Vaccine Immunol (2012) 0.76

Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2011) 0.76

Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States. Int J Med Sci (2004) 0.76

Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr (2015) 0.76

Defining subtypes of Crohn's disease patients: the ground work for translational research in inflammatory bowel disease. J Clin Gastroenterol (2003) 0.75

Is genetic testing in IBD ready for prime time? Am J Gastroenterol (2004) 0.75

Power of linkage analysis using traits generated from simulated longitudinal data of the Framingham Heart Study. BMC Genet (2003) 0.75

Fabrication of magnetic cryptomelane-type manganese oxide nanowires for water treatment. Chem Commun (Camb) (2010) 0.75

Enhanced secondary electron emission from group III nitride/ZnO coaxial nanorod heterostructures. Small (2006) 0.75

[Effect of retinoic acid on alkaline phosphatase expression in rat adipose-derived stem cells]. Nan Fang Yi Ke Da Xue Xue Bao (2012) 0.75

[Clinicopathologic features of ovarian clear cell carcinoma [correction of epithelial ovarian cancer] with yolk sac tumor component: report of a case]. Zhonghua Bing Li Xue Za Zhi (2014) 0.75

Corrigendum: Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes. Sci Rep (2017) 0.75

Genetic determinants of osteoporosis susceptibility in a female Ashkenazi Jewish population. Genet Med (2004) 0.75

Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr (2015) 0.75